Cuiju Tang
Nanjing First Hospital
Professor, Medicine And Medical Sciences
China, People's Republic of
My Publications
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versu...
OncoTargets and Therapy
August 2016